The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.33 | Sales 2021 | 12.35 16.97 | Capitalization | 22.37M 30.75M |
---|---|---|---|---|---|
Net income 2020 | -126M -173M | Net income 2021 | -85M -117M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 40.14M | Net Debt 2021 | 17.1M 23.51M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+43.96% | 6.32B | |
-15.56% | 4.49B | |
-6.52% | 3.3B | |
+5.47% | 3.19B | |
-0.76% | 2.6B | |
+56.34% | 2.05B | |
-4.11% | 1.77B | |
+2.93% | 1.7B | |
-8.02% | 1.63B |